From nature to medicine: snail slime-based functional excipients for oral dosage forms

Abstract

Snail slime, well-known for its outstanding benefits in wound healing and skin disorders, is just beginning to be investigated for its potential in treating gastrointestinal inflammatory diseases. This study presents novel microparticle-based powders as functional excipients for oral dosage forms, produced via spray-drying (SD) of Helix Aspersa Muller snail mucus combined with pectin and starch. Two formulations were developed: SS_SD_40 (40 wt% slime, 60 wt% pectin/starch 1:1) and SS_SD_20 (20 wt% slime, 80 wt % pectin/starch 1:1). Pure slime showed low yield (17.4 % w/w) and high stickiness, whereas blending with pectin and starch improved yields up to 50 %. The resulting powders had well-defined microparticles with diameters of 9.70 μm and 7.56 μm. HPLC analysis confirmed allantoin preservation (>94 % recovery). SS_SD_40 and SS_SD_20 displayed acceptable flowability as a pharmaceutical grade powder, low water content, and mucoadhesiveness under simulated GI conditions. Antioxidant tests revealed dose-dependent radical scavenging, with SS_SD_20 achieving up to 60 % higher activity and lowest IC50 than the other investigated samples. Antiinflammatory effects, assessed by BSA denaturation, were strongest for SS_SD_40 (~90 % inhibition at 2.5 mg/ml and lowest IC50 that the other samples). Both samples showed no cytotoxicity towards Caco-2 cells and reduced IL-6 and IL-8 secretion. The synergistic combination of snail slime, pectin, and starch produced multifunctional, biocompatible powders suitable as new functional excipients for oral formulations.